Primary Gastric Lymphoma in an HIV-Infected Patient

Rodríguez‐Sanjuán, Juan Carlos; Naranjo, Angel; Echevarría, S.; Álvarez-Cañas, Concepción

doi:10.1097/00042560-199612150-00014

Cited by 9 publications

(10 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study represents the largest series of well‐documented HIV‐1 or HIV‐2‐associated MALT lymphomas reported to date. The present patients shared several features with the nineteen cases of MALT lymphoma previously reported in HIV‐1‐infected adults (Coker et al , 1992; Rivas et al , 1993; Rodriguez‐Sanjuan et al , 1996; Wotherspoon et al , 1996; Chetty & Pillay, 1999; Ribeiro et al , 2001; Girard et al , 2005; Cortot et al , 2006) or children (Joshi et al , 1997). In HIV‐1‐infected children, MALT lymphoma was frequently associated with lymphocytic interstitial pneumonitis or lymphoepithelial sialadenitis (Joshi et al , 1997).…”

Section: Characteristics Of Patients and Tumours At The Time Of Maltsupporting

confidence: 85%

“…Most patients reported in the literature were still alive several months after diagnosis, even when they failed to achieve CR. Only two patients died from causes unrelated to lymphoma progression (Rivas et al , 1993; Rodriguez‐Sanjuan et al , 1996). In three patients with HIV‐1‐associated MALT lymphoma, it has been reported that the use of HAART, either alone (Girard et al , 2005) or associated with rituximab (Cortot et al , 2006) or H. pylori eradication therapy (Ribeiro et al , 2001), led to CR of lymphoma, suggesting a possible benefit from the control of HIV‐1 replication.…”

Section: Characteristics Of Patients and Tumours At The Time Of Maltmentioning

confidence: 99%

See 1 more Smart Citation

Mucosa‐associated lymphoid tissue lymphoma in patients with human immunodeficiency virus infection

Boulanger¹,

Meignin

Baia³

et al. 2008

Br J Haematol

View full text Add to dashboard Cite

Section: Characteristics Of Patients and Tumours At The Time Of Maltsupporting

confidence: 85%

Section: Characteristics Of Patients and Tumours At The Time Of Maltmentioning

confidence: 99%

Mucosa‐associated lymphoid tissue lymphoma in patients with human immunodeficiency virus infection

Boulanger¹,

Meignin

Baia³

et al. 2008

Br J Haematol

View full text Add to dashboard Cite

“…These indolent B-cell lymphomas represent 3–7% of HIV-associated lymphomas 27 – 29. Reported subtypes have included follicular lymphoma, B-cell small lymphocytic lymphoma, extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, and monocytoid B-cell lymphoma 28 30 – 34. The low grade lymphomas tend to occur in patients with relatively normal peripheral blood CD4 counts, and patients appear to have a similar median survival to that of HIV-negative patients with these types of lymphoma 28…”

Section: Specific Categories Of Hiv-associated Lymphomamentioning

confidence: 99%

HIV infection and lymphoma

Grogg

Miller

Doğan³

2007

J Clin Pathol

251

206

View full text Add to dashboard Cite

The incidence of lymphoma in patients with HIV infection greatly exceeds that of the general population. The increased risk for lymphoma appears related to multiple factors, including the transforming properties of the retrovirus itself, the immunosuppression and cytokine dysregulation that results from the disease, and, most importantly, opportunistic infections with other lymphotrophic herpes viruses such as Epstein–Barr virus and human herpesvirus 8. Histologically lymphomas fall into three groups: (1) those also occurring in immunocompetent patients; (2) those occurring more specifically in HIV-positive patients; and (3) those also occurring in patients with other forms of immunosuppression. Aggressive lymphomas account for the vast majority cases. They frequently present with advanced stage, bulky disease with high tumour burden and, typically, involve extranodal sites. Clinical outcome appears to be worse than in similar aggressive lymphomas in the general population. However, following the introduction of highly active antiretroviral therapy, the risk for developing lymphoma in the context of HIV infection has decreased and the clinical outcome has improved.

show abstract

“…2 3 Low grade lymphomas in the HIV/AIDS setting are rare, and only a few cases have been documented. [4][5][6][7][8][9] Among these low grade lymphomas, gastric mucosa associated lymphoid tissue (MALT) lymphomas (marginal zone lymphoma of MALT) are even rarer, with only four cases reported in this particular setting. 4 6 7 9 Kaposi sarcoma in any of its epidemiological forms may have visceral involvement, but this most often occurs in the HIV, epidemic type.…”

mentioning

confidence: 99%